002750 *ST龙津药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.829-12.958-9.1830.4851.870
总资产报酬率 ROA (%)-0.678-10.290-7.1280.3711.433
投入资产回报率 ROIC (%)-0.820-12.764-9.0370.4831.860

边际利润分析
销售毛利率 (%)72.07360.88679.20531.07079.657
营业利润率 (%)-18.607-94.589-45.785-0.7773.402
息税前利润/营业总收入 (%)-18.735-96.358-56.456-0.6802.530
净利润/营业总收入 (%)-18.574-97.274-59.796-1.0623.053

收益指标分析
经营活动净收益/利润总额(%)200.73581.12457.524134.710-90.330
价值变动净收益/利润总额(%)-82.520-6.319-11.734-155.38289.403
营业外收支净额/利润总额(%)-2.7920.37318.0851.930-18.194

偿债能力分析
流动比率 (X)7.2637.6605.3744.6105.181
速动比率 (X)6.6697.0885.0574.3204.636
资产负债率 (%)13.01614.32919.06318.00916.281
带息债务/全部投入资本 (%)-4.037-7.499-6.685-4.770--
股东权益/带息债务 (%)-2,437.210-1,328.763-1,458.771-2,080.525-1,830.860
股东权益/负债合计 (%)635.528565.572409.318428.999464.105
利息保障倍数 (X)29.55568.054100.230-6.094-7.259

营运能力分析
应收账款周转天数 (天)64.93462.79578.96620.4390.000
存货周转天数 (天)480.435299.783427.16532.5530.000